Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose-ranging Study to Evaluate the Safety and Efficacy of Olmesartan Medoxomil in Children and Adolescents With Hypertension

NCT00151775 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT00151775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00151775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose-ranging Study to Evaluate the Safety and Efficacy of Olmesartan Medoxomil in Children and Adolescents With Hypertension
Lead sponsor
Daiichi Sankyo
Phase
Phase 2/3
Overall status
Completed
Start date
May 31, 2005
Completion date
September 30, 2008
Enrollment
362 (actual)
Sites
65

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension